- Exchange: Korea SE
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Reyon Pharmaceutical Co Ltd
+ Add to Watchlist102460:KS
22,050 KRW 400 1.85%As of 02:22:59 ET on 05/16/2013.
Snapshot for Reyon Pharmaceutical Co Ltd (102460)
| Open: | 21,400 | Day's Range: | 21,150 - 22,100 | Volume: | 79,067 |
|---|---|---|---|---|---|
| Previous Close: | 21,650 | 52wk Range: | 8,980 - 26,700 | 1-Yr Rtn: | +140.38% |
Key Statistics for 102460
| Current P/E Ratio (ttm) | 16.7426 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. KOSPI | 0.0728 |
| Earnings Per Share (ttm) | 1,317.0000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M KRW) | 284,445.00 |
| Shares Outstanding (M) | 12.90 |
| 30 Day Average Volume | 159,368 |
| Price/Book (mrq) | 2.2512 |
| Price/Sale (ttm) | 2.4878 |
| Dividend Indicated Gross Yield | 0.91% |
| Cash Dividend (KRW) | 200.0000 |
| Last Dividend | 12/27/2012 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 102460
Company Profile & Key Executives for 102460
Reyon Pharmaceutical Co., Ltd. produces over the count drug and raw materials for drug. The products include antibiotics, antiphlogistic, and generic drugs.
| Yoo Sung-RakPresident/CEO/Rep Director | Park Su-CheonVice President |
| Ha Sun-BongVice President | Jang Chung-UngVice President |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
102460 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page